AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 201 min read$CAH

Hollar Jason M. sold $29.4M of CAH

Hollar Jason M. (Chief Executive Officer) sold 124,529 shares of CARDINAL HEALTH INC (CAH) at an average of $235.89 ($233.22–$237.88, $29.38M total) across 10 trades over 2026-08-18 to 2026-08-19.

Original reporting
SEC EDGAR · Hollar Jason M.
Published Aug 20, 2026, 11:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 11:38 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CAH
Bearish
high confidence
Mentioned
$CAH
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CAHBearishMed
01

Why it matters

The CEO's sizable share sale may influence investor sentiment and short‑term price action.

02

Market read

Insider sell by a top executive is a material event for a large‑cap health‑care distributor.

03

What to watch

No 10b5‑1 plan was in place, suggesting the trades were discretionary.

Relevance 7/10Novelty 8/10Timing: filed 2026‑08‑20, immediate market reaction expected

Background

Form 4 filing from SEC EDGAR discloses insider transactions.

Company-level read

Ticker impact

$CAHBearishHigh confidence
Context

CEO Jason Hollar sold 124,529 shares for $29.4M in a Form 4 filing.

Expected impact

Potential short-term dip of 2‑4% as market digests the sale.

Evidence & confidence

The sale size ($29.4M) is material for a large‑cap health‑care distributor and the insider is the CEO, making the signal noteworthy.

Market effects

Sector

May raise concerns for the health‑care distribution sector about executive confidence.

Regional

U.S. market could see modest sell pressure in related distribution stocks.

Global

Limited to investors tracking U.S. health‑care distributors.

Counterpoint

What could challenge this read

The sale could be a routine portfolio rebalancing unrelated to company outlook.

Key entities

  • person
    Jason M. Hollar

    Chief Executive Officer of Cardinal Health

  • company
    Cardinal Health Inc.

    U.S. health‑care services and products distributor

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CAH insider trading history →

Related articles

OCT 1
$MCKMed

McKesson (MCK) and Cardinal Health Extend CVS Health Distributio

McKesson (MCK) and Cardinal Health renewed their pharmaceutical distribution agreements with CVS Health, extending contracts through June 2032. Both companies reaffirmed their fiscal 2027 earnings guidance. McKesson's stock is trading at $890.28, 6.8% above its GF Value of $833.49, with a GF Score of 86/100. Insider sales totaled $28.3 million over the past year, while 15 premium gurus hold MCK with a net positive addition.

gurufocus.com2 min
OCT 1
$CAHMed

Why Is Cardinal Health and McKesson Stock Trading Higher Today - CVS Health (NYSE:CVS), McKesson (NYSE:MC

Cardinal Health (CAH) and McKesson (MCK) extended their distribution agreements with CVS Health (CVS) until 2032. Cardinal Health reaffirmed its 2027 adjusted earnings guidance of $12.40-$12.60 per share, while McKesson reiterated its 2027 outlook of $44.20-$45 per share. Both companies' stocks rose on the news, with McKesson up 4.28% and Cardinal Health up 2.94%.

benzinga.com2 min
OCT 1
$CAHMed

Cardinal Health (CAH) Extends CVS Distribution Deal Through 2032

Cardinal Health (CAH) extended its pharmaceutical distribution agreements with CVS Health through June 2032. The company reaffirmed its fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60 and long-term growth range of 12% to 14%. The deal secures a key partnership and provides revenue visibility, though investors should note non-GAAP exclusions and industry pressures.

gurufocus.com2 min
OCT 1
$CAHMed

Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

CARDINAL HEALTH INC (CAH) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health DUBLIN, Ohio, October 1, 2026 – Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existin

SEC EDGAR 8-K1 min